ARES CAPITAL CORP Q3 FY2026 earnings call

• Strategic Acquisition: Announced agreement to acquire MidCap Financial Investment Corporation (MFIC), expected to be modestly accretive to core EPS. The transaction adds scale, bringing the total portfolio companies to over 800 and expanding sponsor relationships to over 600.
• Portfolio Health: Underlying investment portfolio remains healthy with stable non-occurring loans and problem assets at historically low levels. Borrower cash flow growth supports strong credit performance.
• Origination Activity: Third-quarter origination pace was more modest due to macroeconomic uncertainty and elongated M&A processes, but deal review activity remained strong, with ~25% more transactions reviewed year-to-date compared to the prior year.
• Liquidity and Financing: Maintained substantial liquidity ($7 billion available) and lowered funding costs through new debt issuances and securitization resets. Obtained a $750 million upsize commitment to existing facilities in conjunction with the MFIC acquisition.
• Dividend Stability: Maintained the regular quarterly dividend at $0.48 per share, supported by strong portfolio fundamentals, attractive market pricing, and significant taxable income spillover ($983 million carried forward).
• Market Positioning: Viewed as a natural solution provider in volatile markets, leveraging the broader ARIES platform to secure non-traditional opportunities, such as acquiring a high-quality loan portfolio from an institutional investor at a discount.

The provided transcript does not contain a detailed breakdown of financial performance by specific product segments or their revenue contribution percentages. The company reports consolidated core earnings per share of $0.46 and GAAP net income per share of $0.44 for the third quarter ended September 30, 2026. The total investment portfolio at fair value was $29.2 billion.

• Interest Rate Sensitivity: Management expects to begin seeing interest income benefits from recent base rate increases in the fourth quarter, noting that each 100 basis point increase creates approximately $0.02 per share of earnings tailwind per quarter.
• Forward-Looking Originations: With a current investment backlog of approximately $2.5 billion and $1.1 billion in Q4 originations already closed, management anticipates a recovery and strengthening of investing activity as transaction timelines extend into Q4.
• Dividend Outlook: Confidence in maintaining the current dividend level is reinforced by portfolio strength, favorable market terms, and expected benefits from the MFIC acquisition, despite potential quarterly earnings fluctuations.

• Macroeconomic Uncertainty: Volatility around interest rates, inflation, and global trade has reduced visibility and elongated M&A processes, impacting the pace of new investment activity.
• Credit Performance: While currently healthy, there is inherent risk in the middle-market lending space; however, non-accruals remain at 2.4% of cost, well below historical averages.
• Integration Risks: The successful integration of the MFIC portfolio depends on the quality of due diligence and the ability to manage the added scale, though management cites a strong track record of past acquisitions.
• Maturity Walls: Potential refinancing risks exist for borrowers with maturities in 2028-2029, though management notes that the percentage of maturing debt is typical and manageable through proactive extensions.

Q: Analyst asked if the MFIC acquisition would create additional liquidity beyond capital recycling, given competitors are constrained.

A: CEO confirmed it should boost liquidity further due to competitive strength. CFO noted that larger portfolios naturally generate more repayments (historically 30-35%), providing organic turnover, while also highlighting ARCC's track record of actively selling assets to manage liquidity.

Q: Analyst inquired about the drivers behind the discount to MFIC's NAV and whether this discount structure could be replicated in future acquisitions.

A: CEO explained the discount was concentrated in a small percentage of investments with uncertain outcomes, largely offset by performing assets marked similarly to ARCC's. He noted that while the specific deal terms were favorable due to Aries Management's cash consideration, they cannot speculate on replicating such discounts in future transactions.

Q: Analyst questioned the impact of rising base rates on credit quality, asking if there is a threshold where elevated rates cause meaningful stress.

A: President Jim Miller stated the portfolio has a two-times interest coverage ratio, providing ample cushion. He argued that a 1% rate increase is manageable and net positive for earnings, citing successful navigation of similar environments in 2023 without material credit deterioration.

Q: Analyst asked how the acquired MFIC portfolio compares strategically to ARCC’s current holdings and its exposure to the core middle market.

A: CEO Kort Schnabel described the portfolios as highly complementary, with minimal overlap (only 12 overlapping names). MFIC offers more healthcare allocation and targets the core middle market ($50-$55M EBITDA), balancing ARCC’s software-heavy focus and upper-middle-market orientation, thereby enhancing overall diversification.

Q: Analyst sought clarification on how purchase price discount amortization affects incentive fee calculations for the MFIC acquisition compared to industry norms.

A: CFO Scott Lem indicated he was not aware of standard industry exclusions for discount amortization in incentive fee calculations. He clarified that while capital gains fees might adjust for cost basis, there is no known adjustment on the income side, suggesting ARCC treats accretion like OID without specific fee exclusions.